Efficiency of human monocyte-derived suppressor cell-based treatment in graft-versus-host disease prevention while preserving graft-versus-leukemia effect

BACKGROUND: Immunosuppressive cell-based therapy is a recent strategy for controlling Graft-versus-Host Disease (GvHD). Such cells ought to maintain their suppressive function in inflammatory conditions and in the presence of immunosuppressive agents currently used in allogeneic hematopoietic cell t...

Descripción completa

Detalles Bibliográficos
Autores principales: Janikashvili, Nona, Gérard, Claire, Thébault, Marine, Brazdova, Andrea, Boibessot, Clovis, Cladière, Claudie, Ciudad, Marion, Greigert, Hélène, Ouandji, Séthi, Ghesquière, Thibault, Samson, Maxime, Audia, Sylvain, Saas, Philippe, Bonnotte, Bernard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7899641/
https://www.ncbi.nlm.nih.gov/pubmed/33659098
http://dx.doi.org/10.1080/2162402X.2021.1880046

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7899641/
https://www.ncbi.nlm.nih.gov/pubmed/33659098
http://dx.doi.org/10.1080/2162402X.2021.1880046

Ejemplares similares